Arich Enterprise Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 11, 2020 at 03:25 pm
Share
Arich Enterprise Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 304.315 million compared to TWD 258.935 million a year ago. Operating income was TWD 13.017 million compared to TWD 14.615 million a year ago. Net income was TWD 20.415 million compared to TWD 20.241 million a year ago. Basic earnings per share was TWD 0.3 compared to TWD 0.45 a year ago. For the half year, sales was TWD 757.898 million compared to TWD 599.828 million a year ago. Operating income was TWD 34.803 million compared to TWD 35.888 million a year ago. Net income was TWD 36.485 million compared to TWD 36.289 million a year ago. Basic earnings per share was TWD 0.65 compared to TWD 0.81 a year ago.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 
